Back
Shift4 Payments Vs. Avidity Biosciences Industry Stock Comparison
Buy
99
FOUR
Shift4 Payments
Last Price:
100.77
Seasonality Move:
35.79%
Sell
39
RNA
Avidity Biosciences
Last Price:
46.69
Seasonality Move:
33.04%
Buy
99
Shift4 Payments (FOUR)
is a Buy
Is Shift4 Payments a Buy, Sell or Hold?
- The current Shift4 Payments [FOUR] share price is $100.77. The Score for FOUR is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- FOUR is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $46.71. The Score for RNA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOUR Stock Price Chart
What is Shift4 Payments's stock price today?
-
The Shift4 Payments share price today is $100.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOUR is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $46.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
FOUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.03 | Buy |
| Relative Strength Index (14 RSI): | 72.5 | Buy |
| Chaikin Money Flow: | 684294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (90.77 - 96.13) | Buy |
| Bollinger Bands (100): | (70.24 - 90.22) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 54.01 | Buy |
| Chaikin Money Flow: | 478392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.93 - 47.73) | Buy |
| Bollinger Bands (100): | (41.07 - 46.53) | Buy |
FOUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.58 | Buy |
| 20-day SMA: | 93.77 | Buy |
| 50-day SMA: | 88.32 | Buy |
| 200-day SMA: | 75.22 | Buy |
| 8-day EMA: | 95.26 | Buy |
| 20-day EMA: | 93.22 | Buy |
| 50-day EMA: | 88.66 | Buy |
| 200-day EMA: | 76.92 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.84 | Buy |
| 20-day SMA: | 45.91 | Buy |
| 50-day SMA: | 44.53 | Buy |
| 200-day SMA: | 33.31 | Buy |
| 8-day EMA: | 45.81 | Buy |
| 20-day EMA: | 45.52 | Buy |
| 50-day EMA: | 44.7 | Buy |
| 200-day EMA: | 34.96 | Buy |
Shift4 Payments Earnings Growth & FOUR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and an increase next year of $1.05 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.40 per share.
Shift4 Payments Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||